Page last updated: 2024-08-25

5-hydroxymethyluracil and Myelodysplastic Syndromes

5-hydroxymethyluracil has been researched along with Myelodysplastic Syndromes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abakir, A; Gackowski, D; Gawronski, M; Kerr, C; Maciejewski, JP; Olinski, R; Radivoyevitch, T; Ruzov, A; Starczak, M; Zarakowska, E1

Other Studies

1 other study(ies) available for 5-hydroxymethyluracil and Myelodysplastic Syndromes

ArticleYear
5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively.
    Haematologica, 2020, Volume: 105, Issue:5

    Topics: Biomarkers; Cytosine; Dioxygenases; DNA-Binding Proteins; Humans; Mutation; Myelodysplastic Syndromes; Pentoxyl; Phosphoproteins; Proto-Oncogene Proteins; RNA Splicing Factors

2020